Intensive treatment of hyperglycaemia: ACCORD

The Lancet

Volumn 376, Issue 9739, 2010, Pages 391-392

  Klein, Ronald ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATARACT EXTRACTION; DIABETIC RETINOPATHY; DISEASE DURATION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA MACULA EDEMA; VISUAL ACUITY;

EID: 77955572874     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61028-8     Document Type: Note

References (13)

1. F Ismael-Beigi, T Craven, MA Banerji for the ACCORD trial group Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Lancet 2010 10.1016/S0140-6736(10)60576-4 published online June 29.
2. American Diabetes Association Standards of medical care in diabetes - 2010 Diabetes Care 33 suppl 1 2010 S11 S61
3. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
4. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
5. R Klein, BE Klein, SE Moss, KJ Cruickshanks The Wisconsin Epidemiologic Study of diabetic retinopathy XIV: ten-year incidence and progression of diabetic retinopathy Arch Ophthalmol 112 1994 1217 1228
6. W Duckworth, C Abraira, T Moritz for the VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
7. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
8. MC Riddle, WT Ambrosius, DJ Brillon for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial Diabetes Care 33 2010 983 990
9. L Pogach, D Aron Balancing hypoglycemia and glycemic control: a public health approach for insulin safety JAMA 303 2010 2076 2077
10. FJ Ingelfinger Debates on diabetes N Engl J Med 296 1977 1228 1230
11. RR Holman, SK Paul, MA Bethel, DR Matthews, HA Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
12. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653
13. DM Nathan, B Zinman, PA Cleary and Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005) Arch Intern Med 169 2009 1307 1316